• Login

Alexion Pharmaceuticals

Contact Us Legal Sitemap
  • About Us
  • Soliris in PNH & aHUS
  • R & D
  • Investors
  • Careers
  • News
  • Newsroom Home
  • About Us
  • News Releases
  • By Year
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
  • Financial News
  • Product News
  • Company News
  • Patient Voices
  • Fact Sheets
  • Management Team

Newsroom Search

Advanced Search

Inquiries

Media Contacts

Irving Adler
Exec. Director, Corporate Communications
203-272-2596   
AdlerI@alxn.com

Recent News Releases

  • 5/23/13
    Alexion to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference
  • 5/8/13
    Alexion to Present at the BofA Merrill Lynch 2013 Healthcare Conference
  • 4/25/13
    Alexion Reports First Quarter 2013 Results
  • 4/25/13
    Alexion Broadens and Strengthens its Executive Leadership Team
  • 4/11/13
    Alexion Pharmaceuticals to Report First Quarter 2013 Results on Thursday, April 25, 2013
View all releases morearrow

Patient Voices

Joe E.
Joe E.
PNH Patient
EricaS
Erica S.
aHUS Patient
Evie E.
Evie E.
HPP Patient
Victor E.
Victor E.
PNH Patient
Jill Z.
Jill Z.
aHUS Patient

Please see full Prescribing Information and Important Safety Information for Soliris® (eculizumab).

About Us Soliris & PNH R&D Investors Careers News
Business Wire NewsHQ℠